1. Home
  2. ALLO vs ISTR Comparison

ALLO vs ISTR Comparison

Compare ALLO & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLO
  • ISTR
  • Stock Information
  • Founded
  • ALLO 2017
  • ISTR 2006
  • Country
  • ALLO United States
  • ISTR United States
  • Employees
  • ALLO N/A
  • ISTR N/A
  • Industry
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • ISTR Major Banks
  • Sector
  • ALLO Health Care
  • ISTR Finance
  • Exchange
  • ALLO Nasdaq
  • ISTR Nasdaq
  • Market Cap
  • ALLO 252.9M
  • ISTR 222.8M
  • IPO Year
  • ALLO 2018
  • ISTR 2014
  • Fundamental
  • Price
  • ALLO $1.13
  • ISTR $22.53
  • Analyst Decision
  • ALLO Strong Buy
  • ISTR Buy
  • Analyst Count
  • ALLO 10
  • ISTR 1
  • Target Price
  • ALLO $8.88
  • ISTR $27.00
  • AVG Volume (30 Days)
  • ALLO 3.0M
  • ISTR 35.9K
  • Earning Date
  • ALLO 11-06-2025
  • ISTR 10-20-2025
  • Dividend Yield
  • ALLO N/A
  • ISTR 1.95%
  • EPS Growth
  • ALLO N/A
  • ISTR 46.46
  • EPS
  • ALLO N/A
  • ISTR 2.24
  • Revenue
  • ALLO N/A
  • ISTR $90,651,000.00
  • Revenue This Year
  • ALLO N/A
  • ISTR $11.73
  • Revenue Next Year
  • ALLO $100.00
  • ISTR $60.34
  • P/E Ratio
  • ALLO N/A
  • ISTR $10.11
  • Revenue Growth
  • ALLO N/A
  • ISTR 12.41
  • 52 Week Low
  • ALLO $0.86
  • ISTR $15.39
  • 52 Week High
  • ALLO $3.78
  • ISTR $24.81
  • Technical
  • Relative Strength Index (RSI)
  • ALLO 47.86
  • ISTR 47.53
  • Support Level
  • ALLO $1.09
  • ISTR $22.65
  • Resistance Level
  • ALLO $1.21
  • ISTR $23.02
  • Average True Range (ATR)
  • ALLO 0.07
  • ISTR 0.34
  • MACD
  • ALLO 0.01
  • ISTR -0.13
  • Stochastic Oscillator
  • ALLO 33.33
  • ISTR 4.88

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

Share on Social Networks: